Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
Titel:
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
Auteur:
Bassetti, Matteo Echols, Roger Matsunaga, Yuko Ariyasu, Mari Doi, Yohei Ferrer, Ricard Lodise, Thomas P Naas, Thierry Niki, Yoshihito Paterson, David L Portsmouth, Simon Torre-Cisneros, Julian Toyoizumi, Kiichiro Wunderink, Richard G Nagata, Tsutae D